SOPHiA GENETICS (SOPH) Treasury Shares (2022 - 2025)

SOPHiA GENETICS has disclosed Treasury Shares across 2 years of filings, most recently posting -$719000.0 for Q3 2024.

• Treasury Shares for Q4 2025 came in at -$1.2 million, down 73.5% year-over-year; the trailing twelve-month figure through Dec 2025 was -$1.2 million (down 73.5% YoY), and the FY2025 annual result was -$1.2 million, down 73.5% from the prior year.
• Treasury Shares came in at -$1.2 million for Q4 2025 at SOPHiA GENETICS, down from -$632000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of -$112000.0 in Q1 2023 to a low of -$1.2 million in Q4 2025.
• The 4-year median for Treasury Shares is -$646000.0 (2023), against an average of -$496153.8.
• Peak annual rise in Treasury Shares reached 15.79% in 2023, while the deepest fall reached 452.54% in 2023.
• SOPHiA GENETICS's Treasury Shares stood at -$117000.0 in 2022, then sank by 452.14% to -$646000.0 in 2023, then slipped by 8.67% to -$702000.0 in 2024, then slumped by 73.5% to -$1.2 million in 2025.
• The last three Treasury Shares figures came in at -$1.2 million (Q4 2025), -$632000.0 (Q3 2025), and -$648000.0 (Q2 2025), per Business Quant data.